Yuanyuan Jin

674 total citations
38 papers, 530 citations indexed

About

Yuanyuan Jin is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Yuanyuan Jin has authored 38 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Biomedical Engineering. Recurrent topics in Yuanyuan Jin's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Protein Tyrosine Phosphatases (4 papers). Yuanyuan Jin is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Protein Tyrosine Phosphatases (4 papers). Yuanyuan Jin collaborates with scholars based in China, United States and Japan. Yuanyuan Jin's co-authors include Mingqiang Li, Yu Tao, Haixia Wang, Ke Yi, Shixian Lv, Hanze Hu, Eric Wickstrom, Zhaoyong Yang, Enguo Ju and Weiren Xu and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biomaterials.

In The Last Decade

Yuanyuan Jin

33 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanyuan Jin China 13 295 136 75 62 51 38 530
Jingbin� Huang China 14 361 1.2× 106 0.8× 101 1.3× 55 0.9× 39 0.8× 34 627
Xiaoman Zhou China 14 416 1.4× 80 0.6× 73 1.0× 119 1.9× 36 0.7× 36 613
Li‐Min Xie China 14 352 1.2× 107 0.8× 125 1.7× 57 0.9× 33 0.6× 36 601
Jingbo Yang China 15 310 1.1× 101 0.7× 80 1.1× 68 1.1× 29 0.6× 28 605
Wenjing Xiao China 13 266 0.9× 85 0.6× 95 1.3× 51 0.8× 28 0.5× 30 530
Yaqin Tang China 15 283 1.0× 73 0.5× 65 0.9× 65 1.0× 51 1.0× 59 544
Jialing Chen China 11 325 1.1× 73 0.5× 113 1.5× 54 0.9× 68 1.3× 43 570
Anvar Soleimani Iran 12 236 0.8× 80 0.6× 73 1.0× 79 1.3× 40 0.8× 22 536
Vanessa Moreno Spain 10 360 1.2× 75 0.6× 116 1.5× 68 1.1× 49 1.0× 10 668
Jingqing Le China 13 358 1.2× 180 1.3× 63 0.8× 43 0.7× 59 1.2× 26 552

Countries citing papers authored by Yuanyuan Jin

Since Specialization
Citations

This map shows the geographic impact of Yuanyuan Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanyuan Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanyuan Jin more than expected).

Fields of papers citing papers by Yuanyuan Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanyuan Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanyuan Jin. The network helps show where Yuanyuan Jin may publish in the future.

Co-authorship network of co-authors of Yuanyuan Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanyuan Jin. A scholar is included among the top collaborators of Yuanyuan Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanyuan Jin. Yuanyuan Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhixiang, Wei Liu, Yizhi Chen, et al.. (2025). ER‐phagy Activation by AMFR Attenuates Cardiac Fibrosis Post‐Myocardial Infarction via mTORC1 Pathway. Advanced Science. 12(37). e04552–e04552.
2.
Jin, Yuanyuan, Yi Zhao, Shijie He, et al.. (2025). Aggregation-induced electrochemiluminescence aptasensor for ultrasensitive detection of acetamiprid based on polymer dots as emitters. Biosensors and Bioelectronics. 291. 118031–118031.
3.
Zheng, Ruifang, et al.. (2024). A network pharmacology approach to decipher the mechanism of total flavonoids from Dracocephalum Moldavica L. in the treatment of cardiovascular diseases. BMC Complementary Medicine and Therapies. 24(1). 15–15. 8 indexed citations
4.
Zhang, Jue, Ting Zhang, Ye Yao, et al.. (2024). Low serum total cholesterol levels predict inferior prognosis of patients with POEMS syndrome. Discover Oncology. 15(1). 60–60.
5.
Jin, Yuanyuan, et al.. (2024). Computational design of α-amylase from Bacillus licheniformis to increase its activity and stability at high temperatures. Computational and Structural Biotechnology Journal. 23. 982–989. 5 indexed citations
6.
Yi, Ke, Huimin Kong, Chunxiong Zheng, et al.. (2023). A LIGHTFUL nanomedicine overcomes EGFR-mediated drug resistance for enhanced tyrosine-kinase-inhibitor-based hepatocellular carcinoma therapy. Biomaterials. 302. 122349–122349. 29 indexed citations
7.
Fan, Shuai, et al.. (2022). Structural insights into the specific interaction between Geobacillus stearothermophilus tryptophanyl-tRNA synthetase and antimicrobial Chuangxinmycin. Journal of Biological Chemistry. 298(2). 101580–101580. 8 indexed citations
9.
Jin, Yuanyuan, et al.. (2021). LncRNA MSC‐AS1 motivates the development of melanoma by binding to miR‐302a‐3p and recruiting IGF2BP2 to elevate LEF1 expression. Experimental Dermatology. 30(12). 1764–1774. 11 indexed citations
10.
Han, Dan, Rong Fang, Rong Shi, Yuanyuan Jin, & Qian Wang. (2021). LncRNA NKILA knockdown promotes cell viability and represses cell apoptosis, autophagy and inflammation in lipopolysaccharide-induced sepsis model by regulating miR-140-5p/CLDN2 axis. Biochemical and Biophysical Research Communications. 559. 8–14. 26 indexed citations
11.
Jin, Yuanyuan, Haixia Wang, Ke Yi, et al.. (2020). Applications of Nanobiomaterials in the Therapy and Imaging of Acute Liver Failure. Nano-Micro Letters. 13(1). 25–25. 96 indexed citations
12.
Li, Mingli, Yuanyuan Jin, & Yuanzhi Li. (2019). <p>LncRNA TP73-AS1 Activates TGF-β1 to Promote the Migration and Invasion of Colorectal Cancer Cell</p>. Cancer Management and Research. Volume 11. 10523–10529. 8 indexed citations
13.
Li, Linhu, Yuanyuan Jin, Bin Wang, et al.. (2017). A structure‐based strategy toward the development of novel candidates for antimycobacterial activity: Synthesis, biological evaluation, and docking study. Chemical Biology & Drug Design. 91(3). 769–780. 2 indexed citations
14.
Liu, Juanjuan, et al.. (2017). The antitumor activity and preliminary modeling on the potential mechanism of action of human peroxiredoxin-5. Oncotarget. 8(16). 27189–27198. 5 indexed citations
15.
Jin, Yuanyuan, Linhu Li, Zhaoyong Yang, et al.. (2017). The discovery of a novel compound with potent antitumor activity: virtual screening, synthesis, biological evaluation and preliminary mechanism study. Oncotarget. 8(15). 24635–24643. 9 indexed citations
17.
Wang, Meiyan, Yuanyuan Jin, Lisong Zhang, et al.. (2015). Synthesis, biological evaluation and 3D-QSAR studies of imidazolidine-2,4-dione derivatives as novel protein tyrosine phosphatase 1B inhibitors. European Journal of Medicinal Chemistry. 103. 91–104. 26 indexed citations
18.
Jin, Yuanyuan, et al.. (2014). Fluorescence Detection of KRAS2 mRNA Hybridization in Lung Cancer Cells with PNA-Peptides Containing an Internal Thiazole Orange. Bioconjugate Chemistry. 25(9). 1697–1708. 34 indexed citations
19.
Ma, Ying, Xuejiao Wang, Yuanyuan Jin, et al.. (2014). Design Potential Selective Inhibitors for Treating Cancer by Targeting the Src Homology 2 (SH2) Domain-Containing Phosphatase 2 (Shp2) with Core Hopping Approach. Protein and Peptide Letters. 21(6). 556–563. 11 indexed citations
20.
Jin, Yuanyuan, et al.. (2013). Design of specific inhibitors of the protein tyrosine phosphatase SHP-2 by virtual screening and core hopping method. Molecular Simulation. 40(12). 904–911. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026